» Articles » PMID: 24094325

Global Transcriptional and Translational Repression in Human-embryonic-stem-cell-derived Rett Syndrome Neurons

Abstract

Rett syndrome (RTT) is caused by mutations of MECP2, a methyl CpG binding protein thought to act as a global transcriptional repressor. Here we show, using an isogenic human embryonic stem cell model of RTT, that MECP2 mutant neurons display key molecular and cellular features of this disorder. Unbiased global gene expression analyses demonstrate that MECP2 functions as a global activator in neurons but not in neural precursors. Decreased transcription in neurons was coupled with a significant reduction in nascent protein synthesis and lack of MECP2 was manifested as a severe defect in the activity of the AKT/mTOR pathway. Lack of MECP2 also leads to impaired mitochondrial function in mutant neurons. Activation of AKT/mTOR signaling by exogenous growth factors or by depletion of PTEN boosted protein synthesis and ameliorated disease phenotypes in mutant neurons. Our findings indicate a vital function for MECP2 in maintaining active gene transcription in human neuronal cells.

Citing Articles

Cell type-specific 3D-genome organization and transcription regulation in the brain.

Liu S, Wang C, Zheng P, Jia B, Zemke N, Ren P Sci Adv. 2025; 11(9):eadv2067.

PMID: 40009678 PMC: 11864200. DOI: 10.1126/sciadv.adv2067.


NEAT1-mediated regulation of proteostasis and mRNA localization impacts autophagy dysregulation in Rett syndrome.

Siqueira E, Velasco C, Tarrason A, Soler M, Srinivas T, Setien F Nucleic Acids Res. 2025; 53(4).

PMID: 39921568 PMC: 11806351. DOI: 10.1093/nar/gkaf074.


Cell type-specific weighting-factors to solve solid organs-specific limitations of single cell RNA-sequencing.

Tejima K, Kozawa S, Sato T PLoS Genet. 2024; 20(11):e1011436.

PMID: 39556600 PMC: 11573148. DOI: 10.1371/journal.pgen.1011436.


A genetically encoded actuator boosts L-type calcium channel function in diverse physiological settings.

Del Rivero Morfin P, Chavez D, Jayaraman S, Yang L, Geisler S, Kochiss A Sci Adv. 2024; 10(44):eadq3374.

PMID: 39475605 PMC: 11524184. DOI: 10.1126/sciadv.adq3374.


Modeling antisense oligonucleotide therapy in MECP2 duplication syndrome human iPSC-derived neurons reveals gene expression programs responsive to MeCP2 levels.

Bajikar S, Sztainberg Y, Trostle A, Tirumala H, Wan Y, Harrop C Hum Mol Genet. 2024; 33(22):1986-2001.

PMID: 39277796 PMC: 11555823. DOI: 10.1093/hmg/ddae135.


References
1.
Chahrour M, Jung S, Shaw C, Zhou X, Wong S, Qin J . MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008; 320(5880):1224-9. PMC: 2443785. DOI: 10.1126/science.1153252. View

2.
Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A . Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol. 2006; 26(13):5033-42. PMC: 1489175. DOI: 10.1128/MCB.01665-05. View

3.
Nan X, Campoy F, Bird A . MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997; 88(4):471-81. DOI: 10.1016/s0092-8674(00)81887-5. View

4.
Tullai J, Schaffer M, Mullenbrock S, Sholder G, Kasif S, Cooper G . Immediate-early and delayed primary response genes are distinct in function and genomic architecture. J Biol Chem. 2007; 282(33):23981-95. PMC: 2039722. DOI: 10.1074/jbc.M702044200. View

5.
Kugler S, Kilic E, Bahr M . Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther. 2003; 10(4):337-47. DOI: 10.1038/sj.gt.3301905. View